Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Low testosterone may be responsible for "soft" erections in men. The purpose of our study is to see whether the daily application of a testosterone gel to raise testosterone levels will also increase the "hardness" of a man's erection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes

NCT00440440

Hypogonadism Diabetes

WITHDRAWN PHASE4

A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels

NCT01419236

Ejaculatory Dysfunction Hypogonadism

COMPLETED PHASE2

Efficacy, Pharmacokinetics and Safety of Testosterone

NCT01370369

Testicular Hypogonadism

COMPLETED PHASE2

Testosterone Replacement Therapy in Advanced Chronic Kidney Disease

NCT00645658

Kidney Failure Kidney Diseases

COMPLETED NA

Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes

NCT00141492

Type 2 Diabetes Hypogonadism

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypogonadism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AndroGel (Transdermal Testosterone Gel)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Testosterone \<350 ng/dL,
* 21-59 years of age,
* BMI \<30

Exclusion Criteria

* Those with carcinoma of the breast or known or suspected carcinoma of the prostate or with known hypersensitivity to any of the ingredients in AndroGel.
* Men will be excluded if they have unstable angina, hypertension, diabetes, heart failure, or coronary artery disease.
* Men will agree to discontinue use of current testosterone replacement, as well as Viagra or any other PDE5 inhibitors for 30 days.

Minimum Eligible Age

21 Years

Maximum Eligible Age

59 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes